Niaspan Sales Data

Last updated: February 2014 (updated quarterly).
The following data shows Niaspan U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q3 2013 63 (14) -11.30% -18.73%
Q2 2013 49 (2) -3.62% -7.65%
Q1 2013 47 (1) 4.80% -4.25%
Q4 2012 48 (8) 2.01% -6.36%
Q3 2012 56 (3) 4.70% 6.23%
Q2 2012 59 (5) -1.69% -7.61%
Q1 2012 64 (6) -3.28% -4.74%
Q4 2011 58 (9) -1.11% -4.78%
Q3 2011 49 (4) -11.86% -10.46%
Q2 2011 45 (5) 0.54% -1.02%
Q1 2011 50

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

DateArticle
May 31, 2011Doctors Rethinking Prescribing Abbott's Niaspan
November 25, 2009SDI Reports: Prescriptions for Patients New to Niaspan Rise 41% in Week Following Release of Arbiter 6-HALTS Study Results
Hide
(web2)